ORIN DOUGLAS: Open Payments
NPI 1487810636 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,927 in 129 payments from 9 companies in 2025. Trend: 2023 $2,372 · 2024 $4,142 · 2025 $3,927
Food & beverage: $3,035Consulting: $500Education: $392
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 61 | $1,749 |
| Gilead Sciences, Inc. | 38 | $924 |
| Theratechnologies Inc. | 9 | $769 |
| Merck Sharp & Dohme LLC | 6 | $149 |
| EMD Serono, Inc. | 7 | $142 |
| Napo Pharmaceuticals Inc | 4 | $91 |
| Exact Sciences Corporation | 2 | $51 |
| Lilly USA, LLC | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $24 |
Products named: DOVATO, EGRIFTA, APRETUDE, CABENUVA, PIFELTRO, RUKOBIA, Mytesi, Biktarvy.
Industry payments across NY — which companies pay providers there.
